Economic Evaluation of Posaconazole Versus Standard Azole Therapy as Prophylaxis against Invasive Fungal Infections in Patients with Prolonged Neutropenia in Canada

by Amir A Tahami Monfared, Amy K O’Sullivan, Coleman Rotstein, George Papadopoulos
Published 2012-01-01

Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia

by Joseph P. McEvoy, Peter J. Weiden, Paul H. Lysaker, Xiaowu Sun, Amy K. O’Sullivan
Published 2021-03-01

Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial

by Paul H. Lysaker, Peter J. Weiden, Xiaowu Sun, Amy K. O’Sullivan, Joseph P. McEvoy
Published 2022-08-01

Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder

by Michael J. Doane, Leona Bessonova, Haley S. Friedler, Kathleen M. Mortimer, Harry Cheng, Thomas Brecht, Amy K. O’Sullivan, Hannah Cummings, David McDonnell, Jonathan M. Meyer
Published 2022-02-01

Antipsychotic treatment experiences of people with bipolar I disorder: patient perspectives from an online survey

by Leona Bessonova, Dawn I. Velligan, Peter J. Weiden, Amy K. O’Sullivan, Aaron Yarlas, Martha Bayliss, Nishtha Baranwal, Kaitlin Rychlec, Julia Carpenter-Conlin, Michael J. Doane, Martha Sajatovic
Published 2020-07-01

Unmet needs with antipsychotic treatment in schizophrenia and bipolar I disorder: patient perspectives from qualitative focus groups

by Michael J. Doane, Kimberly Raymond, Cory Saucier, Leona Bessonova, Amy K. O’Sullivan, Michelle K. White, April Mitchell Foster, Kaitlin LaGasse, Julia Carpenter-Conlin, Martha Sajatovic, Dawn I. Velligan
Published 2023-04-01